Nektar Therapeutics
NKTR· Nasdaq
Released Nov 7, 2017, after the close
10-Q filed Nov 8, 2017, 39 days after period end · 0001564590-17-022445
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2017 | Q3 2016 | Q3 2015 | Q3 2014 |
|---|---|---|---|---|
| Revenue | $152.93M | $36.34M | $59.95M | $132.87M |
| Net Income | $60.87M | -$43.22M | -$8.20M | $70.61M |
| EPS Diluted | $0.37 |
Nektar Therapeutics · CIK 906709 · Engraved from SEC EDGAR
| -$0.32 |
| -$0.06 |
| $0.53 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.